{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:48:01Z","timestamp":1792162081283,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd015405","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000}}],"reference-count":72,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015405.pub2","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T09:51:50Z","timestamp":1702029110000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment"],"prefix":"10.1002","volume":"2023","author":[{"given":"Martin","family":"Taylor-Rowan","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences; University of Glasgow; Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A","family":"Alharthi","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences; University of Glasgow; Glasgow UK"},{"name":"Department of Clinical Pharmacy; Umm Al-Qura University; Makkah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna H","family":"Noel-Storr","sequence":"additional","affiliation":[{"name":"Radcliffe Department of Medicine; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyo K","family":"Myint","sequence":"additional","affiliation":[{"name":"Division of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition; University of Aberdeen; Aberdeen UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Stewart","sequence":"additional","affiliation":[{"name":"ACER; IAHS, University of Aberdeen; Aberdeen UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"McCleery","sequence":"additional","affiliation":[{"name":"Oxford Health NHS Foundation Trust; Banbury UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry J","family":"Quinn","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences; University of Glasgow; Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD015405.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/gerona\/gls176","article-title":"Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial","volume":"68","author":"Kersten","year":"2013","journal-title":"Journals of Gerontology: MEDICAL SCIENCES"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1176\/jnp.3.3.314","article-title":"The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home population","volume":"3","author":"Tollefson","year":"1991","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"e019042","DOI":"10.1136\/bmjopen-2017-019042","article-title":"Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: a randomised controlled trial","volume":"8","author":"Van der Meer","year":"2018","journal-title":"BMJ Open"},{"issue":"4","key":"10.1002\/14651858.CD015405.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"e013800","DOI":"10.1136\/bmjopen-2016-013800","article-title":"Deprescribing anticholinergic and sedative medicines: protocol for a feasibility trial (DEFEAT-polypharmacy) in residential aged care facilities","volume":"7","author":"Ailabouni","year":"2017","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0005|cit5","first-page":"100204","article-title":"Cognitive change and antipsychotic medications: results from a pragmatic rater-blind RCT","volume":"26","author":"Anda","year":"2021","journal-title":"Schizophrenia Research: Cognition"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD015405.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1093\/ageing\/afab118.09","article-title":"Potentially inappropriate medication use and mortality in patients with cognitive impairment","volume":"50","author":"Buckley","year":"2021","journal-title":"Age and Ageing"},{"issue":"4","key":"10.1002\/14651858.CD015405.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/jgs.15751","article-title":"Deprescribing in the Pharmacologic Management of Delirium: a Randomized Trial in the Intensive Care Unit","volume":"67","author":"Campbell","year":"2019","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/brain\/115.6.1701","article-title":"Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients","volume":"115","author":"Cooper","year":"1992","journal-title":"Brain"},{"issue":"6","key":"10.1002\/14651858.CD015405.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/2045125314553611","article-title":"Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia","volume":"4","author":"Desmarais","year":"2014","journal-title":"Therapeutic Advances in Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD015405.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004850-200401000-00005","article-title":"Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients","volume":"19","author":"Drimer","year":"2004","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0011|cit11","first-page":"84","article-title":"The effect of the anticholinergic properties of antidepressants on the incidence of dementia: a target trial emulation","volume":"Conference: 37t","author":"Forns","year":"2021","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"10","key":"10.1002\/14651858.CD015405.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/BF03261923","article-title":"Effect of Anticholinergic Use for the Treatment of Overactive Bladder on Cognitive Function in Post-Menopausal Women","volume":"32","author":"Geller","year":"2012","journal-title":"Clinical Drug Investigation"},{"issue":"1","key":"10.1002\/14651858.CD015405.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12877-020-1474-7","article-title":"Effect of mirabegron on cognitive function in elderly patients with overactive bladder: moCA results from a phase 4 randomized, placebo-controlled study (PILLAR)","volume":"20","author":"Griebling","year":"2020","journal-title":"BMC Geriatrics"},{"issue":"1","key":"10.1002\/14651858.CD015405.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/pharmacy6010007","article-title":"Effects of pharmacists' interventions on inappropriate drug use and drug-related readmissions in people with dementia-a secondary analysis of a randomized controlled trial","volume":"6","author":"Gustafsson","year":"2018","journal-title":"Pharmacy"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0015|cit15","first-page":"100690","article-title":"Protocol for a multicenter randomized, double blind, controlled pilot trial of higher neural function in overactive bladder patients after anticholinergic, beta-3 adrenergic agonist, or placebo","volume":"20","author":"High","year":"2020","journal-title":"Contemporary Clinical Trials Communication"},{"issue":"3","key":"10.1002\/14651858.CD015405.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jagp.2017.08.005","article-title":"Reduction of the Anticholinergic Burden Makes It Possible to Decrease Behavioral and Psychological Symptoms of Dementia","volume":"26","author":"Jaidi","year":"2018","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD015405.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jamda.2018.10.015","article-title":"Threshold for a reduction in anticholinergic burden to decrease behavioral and psychological symptoms of dementia","volume":"20","author":"Ja\u00efdi","year":"2019","journal-title":"Journal of the American Medical Directors Association"},{"issue":"2","key":"10.1002\/14651858.CD015405.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3233\/NRE20100590","article-title":"Do anticholinergics affect reaction time? A possible impact on the course of rehabilitation","volume":"27","author":"Karatas","year":"2010","journal-title":"NeuroRehabilitation"},{"issue":"4","key":"10.1002\/14651858.CD015405.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"e032851","DOI":"10.1136\/bmjopen-2019-032851","article-title":"Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome","volume":"10","author":"Lim","year":"2020","journal-title":"BMJ Open"},{"issue":"9","key":"10.1002\/14651858.CD015405.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"e1270","DOI":"10.4088\/JCP.16m11269","article-title":"Reducing anticholinergic medication burden in patients with psychotic or bipolar disorders","volume":"78","author":"Lupu","year":"2017","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD015405.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.12788\/acp.0019","article-title":"Less is more: deprescribing anticholinergic medications in persons with severe mental illness","volume":"33","author":"Lupu","year":"2021","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0022|cit22","first-page":"20","article-title":"A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function","volume":"48","author":"McEvoy","year":"1987","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD015405.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13195-017-0263-9","article-title":"Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden","volume":"9","author":"Moga","year":"2017","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0024|cit24","first-page":"89","article-title":"Anticholinergic medications and cognitive function in the elderly","volume":"10","author":"Molloy","year":"1989","journal-title":"Journal of Clinical and Experimental Gerontology"},{"issue":"4","key":"10.1002\/14651858.CD015405.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1212\/WNL.44.4.657","article-title":"Attention deficit in Alzheimer's disease is not simulated by an anticholinergic\/antihistaminergic drug and is distinct from deficits in healthy aging","volume":"44","author":"Oken","year":"1994","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD015405.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"e0149984","DOI":"10.1371\/journal.pone.0149984","article-title":"Deprescribing in frail older people: a randomised controlled trial","volume":"11","author":"Potter","year":"2016","journal-title":"PLOS One"},{"issue":"4","key":"10.1002\/14651858.CD015405.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ageing\/afac092","article-title":"Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial)","volume":"51","author":"Roughead","year":"2022","journal-title":"Age and Ageing"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/IPRP.S176653","article-title":"Anticholinergic discontinuation and cognitive functions in patients with schizophrenia: a pharmacist-physician collaboration in the outpatient department","volume":"7","author":"Sathienluckana","year":"2018","journal-title":"Integrated Pharmacy Research and Practice"},{"issue":"5","key":"10.1002\/14651858.CD015405.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1001\/archpsyc.1987.01800170032006","article-title":"Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study","volume":"44","author":"Sunderland","year":"1987","journal-title":"Archives of General Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD015405.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s00213-014-3794-9","article-title":"Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers","volume":"232","author":"Veselinovic","year":"2015","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1002\/14651858.CD015405.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.7326\/M16-2729","article-title":"Discontinuing inappropriate medication use in nursing home residents: a cluster randomized controlled trial","volume":"167","author":"Wouters","year":"2017","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/ggi.12000","article-title":"Potential benefits of reducing medication-related anticholinergic burden for demented older adults: a prospective cohort study","volume":"13","author":"Yeh","year":"2013","journal-title":"Geriatrics & Gerontology International"},{"issue":"5","key":"10.1002\/14651858.CD015405.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.sapharm.2020.10.010","article-title":"Reducing anticholinergic medication exposure among older adults using consumer technology: protocol for a randomized clinical trial","volume":"17","author":"Abebe","year":"2021","journal-title":"Research in Social & Administrative Pharmacy"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD015405.pub2-BIB0034|cit34","first-page":"S193","article-title":"R2D2: a cluster-randomized trial of deprescribing to support brain health","volume":"70","author":"Campbell","year":"2022","journal-title":"Epidemiology (Cambridge, Mass.)"},{"issue":"3","key":"10.1002\/14651858.CD015405.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","article-title":"Impact of anticholinergics on the aging brain: a review and practical application","volume":"4","author":"Boustani","year":"2008","journal-title":"Aging Health"},{"issue":"12","key":"10.1002\/14651858.CD015405.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1111\/j.1532-5415.2004.52563.x","article-title":"The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice?","volume":"52","author":"Carnahan","year":"2004","journal-title":"Journal of the American Geriatriatics Society"},{"issue":"12","key":"10.1002\/14651858.CD015405.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1177\/0091270006292126","article-title":"The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity","volume":"46","author":"Carnahan","year":"2006","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0038|cit38","unstructured":"Comprehensive Meta-Analysis Version 3 Borenstein M Hedges L Higgins J Englewood: NJ 2013"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0039|cit39","unstructured":"Covidence Veritas Health Innovation"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0040|cit40","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","author":"American Psychiatric Association","year":"2013"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0043|cit43","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"issue":"7","key":"10.1002\/14651858.CD015405.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"issue":"2","key":"10.1002\/14651858.CD015405.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1370\/afm.2501","article-title":"Assessing risks of polypharmacy involving medications with anticholinergic properties","volume":"18","author":"Hanlon","year":"2020","journal-title":"Annals of Family Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD015405.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0047|cit47","doi-asserted-by":"crossref","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6","DOI":"10.1002\/9781119536604"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0048|cit48","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3 2022"},{"issue":"8","key":"10.1002\/14651858.CD015405.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/archinte.167.8.781","article-title":"A drug burden index to define the functional burden of medications in older people","volume":"167","author":"Hilmer","year":"2007","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"g1678","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD015405.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/gerona\/gls176","article-title":"Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial","volume":"68","author":"Kersten","year":"2013","journal-title":"Journals of Gerontology Series A: Biological Sciences and Medical Sciences"},{"issue":"6","key":"10.1002\/14651858.CD015405.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/jnc.15244","article-title":"Tardive neurotoxicity of anticholinergic drugs: a review","volume":"158","author":"Marzoughi","year":"2021","journal-title":"Journal of Neurochemistry"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/archneur.58.11.1803","article-title":"Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease","volume":"58","author":"McKhann","year":"2001","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer's & Dementia"},{"issue":"2","key":"10.1002\/14651858.CD015405.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jamda.2019.06.001","article-title":"Interventions to reduce anticholinergic burden in adults aged 65 and older: a systematic review","volume":"21","author":"Nakham","year":"2020","journal-title":"Journal of the American Medical Directors Association"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"Journal of the American Geriatric Society"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0059|cit59","unstructured":"National Institute for Health and Care Excellence Dementia: assessment, management and support for people living with dementia and their carers. NICE, 2023 Available at www.nice.org.uk\/guidance\/ng97"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.56.9.1133","article-title":"Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"56","author":"Petersen","year":"2001","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0061|cit61","unstructured":"Prince M Comas-Herrera A Knapp M Guerchet M Karagiannidou M Improving healthcare for people living with dementia: coverage, quality and costs now and in the future. ADI, 2016 www.alzint.org\/resource\/world-alzheimer-report-2016\/"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"Rom\u00e1n","year":"1993","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD015405.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1111\/bcp.15261","article-title":"Higher anticholinergic burden from medications is associated with significant increase in markers of inflammation in the EPIC-Norfolk prospective population-based cohort study","volume":"88","author":"Sanghavi","year":"2022","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD015405.pub2-BIB0064|cit64","doi-asserted-by":"crossref","DOI":"10.1002\/gps.5722","article-title":"A systematic review of interventions to reduce anticholinergic burden in older people with dementia in primary care","volume":"37","author":"Shawaqfeh","year":"2022","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD015405.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/thoraxjnl-2011-201275","article-title":"Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications","volume":"68","author":"Singh","year":"2013","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD015405.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3233\/JAD-180353","article-title":"Anticholinergic burden and risk of stroke and death in people with different types of dementia","volume":"65","author":"Tan","year":"2018","journal-title":"Journal of Alzheimer's Disease"},{"issue":"5","key":"10.1002\/14651858.CD015405.pub2-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013540.pub2","article-title":"Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome","author":"Taylor-Rowan","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD015405.pub2-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015196.pub2","article-title":"Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia","author":"Taylor-Rowan","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"e019042","DOI":"10.1136\/bmjopen-2017-019042","article-title":"Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: a randomised controlled trial","volume":"8","author":"Van der Meer","year":"2018","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD015405.pub2-BIB0071|cit71","volume-title":"International Classification of Diseases (ICD) (who.int)","author":"World Health Organization","year":"1993"},{"issue":"12","key":"10.1002\/14651858.CD015405.pub2-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015405","article-title":"Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment","author":"Taylor-Rowan","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:02:04Z","timestamp":1747306924000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015405.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":72,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015405.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,8]]}}}